This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Amniotics Ab. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations by Andreas Nils Walter Herbst
Introduction
Andreas Nils Walter Herbst is a notable inventor based in Bjarred, Sweden. He has made significant contributions to the field of medical technology, particularly in the area of umbilical cord blood collection and cell isolation. His work has implications for cell-based therapeutics, showcasing the potential of innovative methods in healthcare.
Latest Patents
Herbst holds a patent for "Methods and apparatuses for umbilical cord blood collection and isolation of cells." This invention relates to a method for the separation of cord blood endothelial cells from hematopoietic cells. It preserves the repopulating ability and primitivity of hematopoietic cells without significantly reducing their yield. The endothelial cells obtained from cord blood have utility in cell-based therapeutics. The system described in the patent takes advantage of the endogenous adherence properties of the cells to facilitate their separation and separate storage.
Career Highlights
Throughout his career, Andreas has worked with companies such as Amniotics AB and Longboat Amniotics AB. His experience in these organizations has contributed to his expertise in the field of cell therapy and regenerative medicine.
Collaborations
Some of his notable coworkers include Marcus Kare Torleif Larsson and Niels-Bjarne Roland Woods. Their collaboration has likely enriched the research and development processes in which they have been involved.
Conclusion
Andreas Nils Walter Herbst's innovative work in umbilical cord blood collection and cell isolation exemplifies the impact of inventions in the medical field. His contributions continue to influence advancements in cell-based therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile